Parkinson's UK
Matthew Durdy is an accomplished executive with extensive experience in the biotechnology and finance sectors. Currently serving as Chief Executive at Cell and Gene Therapy Catapult since January 2013, Matthew is responsible for developing and implementing strategic initiatives, overseeing business development, and managing stakeholder engagement. Additionally, Matthew holds leadership positions as Chair of Parkinson's Research Ventures Limited and Board Trustee for Parkinson's UK. Previous roles include Chief Executive at Aqix Limited and Managing Director at Biotec Laboratories Ltd, where significant improvements in strategy and funding were achieved. Matthew's early career includes key positions at CDC Group plc and Bank of America, with a strong educational background from The University of Chicago Booth School of Business and the University of Oxford.
This person is not in any teams
This person is not in any offices
Parkinson's UK
1 followers
Your mum, colleague or friend. Anyone can get Parkinson’s, young or old. Every hour, two more people are diagnosed. Unlocking new treatments means delving into the causes of Parkinson’s. That’s why we fund the Parkinson's UK Brain Bank – the world's only brain bank dedicated to Parkinson's research. Over 10,000 people have donated their brains to help scientists around the world to unravel the mysteries of the condition and develop better treatments. The largest charitable funder of Parkinson’s research in Europe, we’re close to major breakthroughs. So we set up the Parkinson’s Virtual Biotech, fast tracking the most promising scientific discoveries into life-changing new treatments. Collaborative, risk-taking, and bold, we’re the only Parkinson’s charity working in this way. We’ll break through barriers in drug development and make new treatments a reality. Until then, we're here for everyone affected by Parkinson’s. Fighting for fair treatment and better services. Making everyone see its real impact. Parkinson’s has over 40 symptoms, from tremor and pain to anxiety. Some are treatable, but the drugs can have serious side effects. And it gets worse over time. But people don’t understand Parkinson’s. We campaign to challenge this and make more people care. We influence policymakers to consider Parkinson’s when developing government programmes. We've achieved 63 positive policy changes since 2015 . We are Parkinson's UK. Powered by people. Funded by you. Together we'll find a cure.